Multi-component automated collection - Novel tendency in blood donating;Multikomponentní automatizované odběry - Nový trend v dárcovství krve

Vnitrni Lekarstvi

Volumn 51, Issue 3, 2005, Pages 320-326

  Procházková, Renata ^a  

^a Krajska Nemocnice Liberec   (Czech Republic)

Author keywords

Apheresis; Effectivity of the method; Inclusion criteria for blood donor; Multi component blood collection; Quality of transfusion preparations; Transfusion

Indexed keywords

BETA THROMBOGLOBULIN; RANTES; THROMBOCYTE FACTOR 4; TRANSFORMING GROWTH FACTOR BETA;

APHERESIS; AUTOMATION; BLOOD DONOR; HUMAN; REVIEW; TRANSFUSION;

EID: 20344370493     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Adam Z, Vorlíček J, Koptíková J. Obecná onkologie a podpůrná léčba. Praha: Grada 2003.
2. Bandarenko N. The selection and care of multiple component apheresis donors: a medical perspective. Annual meeting AABB Symposium: Orlando, USA 2002.
3. Bláha M, Turek P, Gašová Z et al. Hemaferéza v České republice. Vnitř Lék 2003; 49(2): 153-154.
4. Bláha M et al. Rizika hemaferéz. Hematologie a transfuziologie 1992; 4: 33-42.
5. Blanco L. Tailored collection of multicomponent by apheresis. Transfus Apher Sci 2002; 27(2): 123-127.
6. Bolan CD, Greer SE, Cecco SA et al. Comprehensive analysis of citrat effects during platepheresis in normal donors. Transfusion 2001; 41(9): 1165-1171.
7. Čermák J, Brabec V. Klinický význam vyšetření hladiny cirkulujících transferinových receptorů v séru. Vnitř Lék 1999; 8: 468-472.
8. Elfath MD, Whitley P, Jacobson MS et al. Evaluation of an automated system for the collection of packed RBCs, platelets, and plazma. Transfusion 2000; 40(10): 1214-1222.
9. Furuta M, Shimizu T, Mizuno S et al. Clinical evaluation of repeat apheresis donors in Japan. Vox Sanq 1999; 77(1): 17-23.
10. Gable RG, Edwards RL. The use of platelet concentrates versus platepheresis - the donor perspective. Transfusion 2001; 41: 727-729.
11. Gemmell C. Activation of platelets by in vitro whole blood contact with materials: Increases in microparticle, procoagulant activity and soluble P-selectin blood levels. J Biomater Sci Polym Ed 2001; 12(8): 933-943.
12. Goodnough LT, Shander A, Brecher ME. Transfusion medicine: looking to the future. Lancet 2003; 361(9352): 161-188.
13. Guide to the preparation, use and quality assurance of blood components. 9th ed. Strasburg: Council of Europe Publishing 2003.
14. Hocker P. Red cell apheresis in autologous preoperative blood donation. Transf Apher Sci 2001; 24(1): 75-78.
15. Hogler W, Mayer W, Messmer C et al. Prolonged iron depletion after allogenetic 2-unit apheresis. Transfusion 2001; 41(5): 602-605.
16. Holme S, Elfath MD, Whitley P. Evaluation of in vivo and in vitro quality of apheresis collected RBC stored for 42 days. Vox Sanq 1998; 75(3): 212-217.
17. Chrobák L. Mikrocytární a hypochromní anémie. Vnitř Lék 2001; 47(3): 166-174.
18. Koubek K. CD nomenklatura leukocytárních antigenů. Vnitř Lék 2003; 49(1): 66-72.
19. Krailadsiri P, Seghatchian J, Williamson LM. Platelet storage lession of WBC-reduced, pooled buffy coat-derived platelet concentrates prepared in three in-process filter/storage bag combinations. Transfusion 2001; 41(2): 243-250.
20. Krailadsiri P, Seghatchian J. Effect of processing and storage on platelet activation, cellular injury and microvesiculation. Transf Apher Sci 2001; 24(3): 237-238.
21. Krailadsiri, P., Seghatchian, J.: Are all leucodepleted platelet concentrates equivalent? Comparison of Cobe LRS Turbo, Haemonetics MCS+ LD, and filtered pooled buffy-coat-derived platelets. Vox Sanq 2000; 78(3): 171-175.
22. Kubešová H, Krahulcová E, Kiss I et al. Substituce krevními deriváty v období dřeňové aplázie u nemocných po agresivní chemoterapii zhoubných hematologických onemocnění. Vnitř Lék 1993; 39(5): 430-436.
23. Leitner GC, Stohlawetz PJ, Stiegler PJ et al. Quality of packed red blood cells and platelet concentrates by multicomponent collection using the MCS Plus device. J Clin Apheresis 2003; 18(1): 21-25.
24. Loudová M, Krejsek J, Kopecký O et al. Cytoimunofluorometrie a její využití v detekci aktivované destičky. Vnitř Lék 2001; 47(3): 175-180.
25. Makar YF, Butler MO, Cockersole GM et al. National audit of citrate toxicity in plateletpheresis donors. Transfus Med 2002; 12(3): 187-191.
26. Matthes GA. Options and cost effectiveness of multicomponent blood collection. Transf Apher Sci 2002; 27(2): 115-121.
27. Moog R, Bartsch R, Muller N. Concurent collection of in-line filtered platelets and red cells by apheresis. Ann Hematol 2002; 81(6): 322-325.
28. Moog R, Franck V, Pierce JA et al. Evaluation of a concurrent multicomponent collection system for the collection and storage of WBC - reduced RBC apheresis concentrates. Transfusion 2001; 41(9): 1159-1164.
29. Moore SB, Winters JL. Multiple blood donations and iron deficiency in patients with Restless legs syndrome. Mayo Clin Proc 2003; 78(5): 654-656.
30. Novosad J, Kodydková K, Krejsek J. Apoptóza, její mechanizmy a medicínský význam. I. Definite apoptózy a její průběh na bunéčné úrovni. Vnitř Lék 2001; 47(6): 381-386.
31. Novosad J, Kodydková K, Krejsek J. Apoptóza, její mechanizmy a medicínský význam. II. Poruchy regulace apoptózy a jejich souvislost s rozvojem onemocnění. Vnitř Lék 2001; 47(6): 387-390.
32. Quendro I, Moog R, Muller N. A questionainre: will plateletpheresis donors accept multicomponent donation? Transfus Apher Sci 2002; 27(2): 95-99.
33. Recommendations for collecting red blood cells by automated apheresis methods. FDA Draft Guidance for Industry (Docket Number 98D-0545). Rockville, MD: FDA July 1998.
34. Regan F, Teesdale P, Garner S et al. Comparsion of in vivo red cell survival of donations collected by Haemonetics MCS versus conventional collection. Transfus Med 1997; 7(1): 25-28.
35. Seghatchian J, Krailadsiri P. Red cell storage lesion assesed by the levels of potassium, hemoglobin and annexin V in supernatantant. Transfus Apher Sci 2002; 26(2): 121-127.
36. Seghatchian J, Krailadsiri P, Dilger P et al. Cytokines as quality indicators of leucoreduced red cell concentrates. Transfus Apher Sci 2002; 26(1): 43-46.
37. Seghatchian MJ, Wadhwa M, Thorpe R. Cytokines in Platelet Concentrates: A Comparsion of Apheresis Platelet (Haemonetics) and Filtered and Unfiltered Pooled Buffy - Coat Derived Platelet Concentrates. Transfus Sci 1997; 18(1): 103-107.
38. Shi PA, Ness PM. Two-unit red cell apheresis and int potential advatages over traditional whole-blood donation. Transfusion 1999; 39(2): 218-225.
39. Silberman S. Platelets: preparations, transfusion modifications and substitutes. Arch Pathol Lab Med 1999; 123(10): 889-894.
40. Stohlawetz PO, Hergovich N, Stiegler G et al. Differential induction of P selectin on platelets by two cell separators during platepheresis and the effect on the release of soluble P-selectin. Transfusion 1998; 38(3): 24-30.
41. Straub J, Kolešková E, Haber J. Sideropenická anémie jako projev selektivní malabsopce železa. Vnitř Lék 2001; 47(7): 493-495.
42. Ščudla V, Adam Z, Ščudlová M. Současné možnosti diagnostiky a léčby anémie chronických chorob. Vnitř Lék 2001; 47(6): 400-406.
43. Tzima E, Walker JH. Platelet annexin V: the ins and outs. Platelets 2000; 11: 245-251
44. Valbonesi M, Bruni R, Bo A et al. Double platepheresis (DPA) and tailored RBC collection with the Excel-Pro: preliminary results. Transf Apher Sci 2001; 24(1): 71-73.
45. Vášová I, Mayer J. Biologické účinky alogenních leukocytů a deleukotizace buněčných krevních derivátů. Vnitř Lék 1995; 41(10): 713-718.
46. Wadhwa M, Seghatchian MJ, Dilger P et al. Cytokines in WBC-reduced apheresis PCs during storage: a comparsion of two WBC-reduction methods. Transfusion 2000; 40(9): 1118-1126.
47. Western KH, Videm V. Donor neutrophil function after plateletpheresis. Transfusion 2000; 40(11): 1414-1418.
48. Zeiler TA, Kretschmer V. Automated blood component collection with the MCS 3p cell separator: evaluation of three protocols for buffy coat-poor and white cell-reduced packed red cells and plazma. Transfusion 1997; 37(8): 791-797.
49. Zingsem J, Weisbach V, Zimmermann R et al. Preparation of FFP as byproduct of plateletpheresis. Transfusion 2001; 42(1): 81-86.